Dell Children's Medical Group

Austin, Texas 78723

3 studies enrolling now · 7 studies all time

What they study most

Cystic Fibrosis, ISS, Ig-E Mediated Food Allergy, NonSegmental Vitiligo, Recessive Dystrophic Epidermolysis Bullosa, SGA

Studies at this site

• Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy — Recruiting now
• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo — Recruiting now
• Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature. — Recruiting now
• A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa — Running, not enrolling
• Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
• A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis — Completed
• A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes) — Completed